These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10815373)

  • 41. Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe.
    Fuchs S; Olberg B; Perleth M; Busse R; Panteli D
    Health Policy; 2019 Feb; 123(2):173-181. PubMed ID: 29703653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EUnetHTA's contribution to the new legal framework for health technology assessment cooperation in Europe.
    Imaz-Iglesia I; Wild C
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e50. PubMed ID: 35652661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An international survey of the public engagement practices of health technology assessment organizations.
    Whitty JA
    Value Health; 2013; 16(1):155-63. PubMed ID: 23337227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing understanding: the development of a glossary of health technology assessment adaptation terms.
    Rosten C; Chase DL; Hicks NJ; Milne R;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():42-7. PubMed ID: 20030890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systems to support health technology assessment (HTA) in member states of the European union with limited institutionalization of HTA.
    Moharra M; Espallargues M; Kubesch N; Estrada MD; Parada A; Vondeling H; Lo Scalzo A; Cristofides S; Turk E; Raab M;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():75-83. PubMed ID: 20030894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health technology assessment agencies: an international overview of organizational aspects.
    Martelli F; La Torre G; Di Ghionno E; Staniscia T; Neroni M; Cicchetti A; Von Bremen K; Ricciardi W;
    Int J Technol Assess Health Care; 2007; 23(4):414-24. PubMed ID: 17937828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration.
    Luhnen M; Ormstad SS; Willemsen A; Schreuder-Morel C; Helmink C; Ettinger S; Erdos J; Fathollah-Nejad R; Rehrmann M; Hviding K; Rüther A; Chalon PX
    Int J Technol Assess Health Care; 2021 Apr; 37(1):e59. PubMed ID: 33902782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of consumers in health technology assessment activities by Inahta agencies.
    Hailey D; Werkö S; Bakri R; Cameron A; Göhlen B; Myles S; Pwu J; Yothasamut J
    Int J Technol Assess Health Care; 2013 Jan; 29(1):79-83. PubMed ID: 23217279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postlaunch evidence generation practices among health technology assessment bodies in Europe.
    Puñal-Riobóo J; Varela-Lema L; Guilhaume C; Galbraith M; Bélorgey C; Faraldo MJ; Meillassoux A
    Int J Technol Assess Health Care; 2022 Apr; 38(1):e33. PubMed ID: 35437135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Most important barriers and facilitators of HTA usage in decision-making in Europe.
    Cheung KL; Evers SMAA; De Vries H; Levy P; Pokhrel S; Jones T; Danner M; Wentlandt J; Knufinke L; Mayer S; Hiligsmann M
    Expert Rev Pharmacoecon Outcomes Res; 2018 Jun; 18(3):297-304. PubMed ID: 29303374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Priority setting for health technology assessment. Theoretical considerations and practical approaches. Priority setting Subgroup of the EUR-ASSESS Project.
    Henshall C; Oortwijn W; Stevens A; Granados A; Banta D
    Int J Technol Assess Health Care; 1997; 13(2):144-85. PubMed ID: 9194351
    [No Abstract]   [Full Text] [Related]  

  • 53. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts.
    Chase D; Rosten C; Turner S; Hicks N; Milne R
    Health Technol Assess; 2009 Nov; 13(59):1-142, iii. PubMed ID: 19958718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.
    Martelli N; Billaux M; Borget I; Pineau J; Prognon P; van den Brink H
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):12-8. PubMed ID: 25991072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of the International Network of Agencies for Health Technology Assessment.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():24-7. PubMed ID: 19500434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta).
    Merlin T; Tamblyn D; Ellery B;
    Int J Technol Assess Health Care; 2014 Oct; 30(4):430-7. PubMed ID: 25397872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach.
    van der Wilt GJ; Bloemen B; Grin J; Gutierrez-Ibarluzea I; Sampietro-Colom L; Refolo P; Sacchini D; Hofmann B; Sandman L; Oortwijn W
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e52. PubMed ID: 35959563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of patient involvement in a health technology assessment.
    Dipankui MT; Gagnon MP; Desmartis M; Légaré F; Piron F; Gagnon J; Rhiands M; Coulombe M
    Int J Technol Assess Health Care; 2015 Jan; 31(3):166-70. PubMed ID: 26062904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.